Premature Ovarian Insufficiency Linked to Osteoporosis
THURSDAY, March 4, 2021 -- Premature ovarian insufficiency (POI) is associated with osteoporosis, according to a study published online March 1 in Menopause.
Alison K. Shea, M.D., Ph.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues examined the correlation of POI and early menopause with bone mineral density (BMD) and osteoporosis among female participants of the Canadian Longitudinal Study on Aging.
The researchers observed no difference in hip BMD for women with POI compared with those with early and normal age of menopause; however, women in the POI group were more likely to have self-reported osteoporosis (21.9 versus 16.7 percent) and to have used osteoporosis drugs (11.39 versus 7.63 percent). POI was associated with increased odds of osteoporosis, as diagnosed using BMD, after adjustment. This association was influenced by current cigarette smoking. Obesity and current hormone therapy use were protective factors, but the duration of hormone therapy use was not. The likelihood of being obese, having reduced physical activity, and being a current smoker was higher for women in the POI group.
"An early loss of ovarian function prior to age 40 years is associated with BMD-measured osteoporosis," the authors write. "Increasing understanding of the sequelae associated with an earlier loss of ovarian function will aid in targeting earlier screening and intervention strategies for women in Canada and abroad."
One author disclosed financial ties to Pfizer and BioSyent.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
TUESDAY, April 13, 2021 -- Reimbursement for hospital charges is increasing faster than payments for surgeons performing hip fracture surgeries on Medicare beneficiaries,...
WEDNESDAY, March 31, 2021 -- The age-adjusted prevalence of osteoporosis at either the femur neck or lumbar spine or both was 12.6 percent among adults aged 50 years and older in...
MONDAY, March 29, 2021 -- In new joint guidelines issued by bone health experts, recommendations are presented for managing osteoporosis therapy in the context of COVID-19...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.